Cargando…
Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells
Neuroblastoma is the most common extracranial tumor in childhood. Outcome of stage 4 disease remains poor and the development of novel therapeutic approaches is thus urgently needed. Taurolidine (TRD), originally invented to avoid catheter infections, has shown to exhibit antineoplastic activity in...
Autores principales: | Eschenburg, Georg, Luckert, Christian, Reinshagen, Konrad, Bergholz, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279442/ https://www.ncbi.nlm.nih.gov/pubmed/25568670 |
Ejemplares similares
-
Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L
por: Najem, Safiullah, et al.
Publicado: (2016) -
Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α
por: Langemann, Doerte, et al.
Publicado: (2017) -
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (Review)
por: MÖHLER, HANS, et al.
Publicado: (2014) -
NEC is likely a NETs dependent process and markers of NETosis are predictive of NEC in mice and humans
por: Vincent, Deirdre, et al.
Publicado: (2018) -
Abstract: Suture Materials Containing the Antimicrobial Taurolidine
por: Lorenc, Z. Paul, et al.
Publicado: (2016)